SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 4,481.84 |
| Enterprise Value ($M) | 4,211.25 |
| Book Value ($M) | -135.37 |
| Book Value / Share | -1.14 |
| Price / Book | -33.11 |
| NCAV ($M) | -429.11 |
| NCAV / Share | -3.62 |
| Price / NCAV | -10.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.73 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.17 |
| Current Ratio | 6.17 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,107.94 |
| Assets | 1,401.67 |
| Liabilities | 1,537.05 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 18.47 |
| Operating Income | -536.25 |
| Net Income | -589.53 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -395.89 |
| Cash from Investing | -553.10 |
| Cash from Financing | 930.61 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 9.40 | -10.22 | |
| 13G/A | Vanguard Group Inc | 10.09 | 1.31 | |
| 13G | T. Rowe Price Investment Management, Inc. | 8.20 | ||
| 13G/A | BlackRock, Inc. | 13.00 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 366,681 | 1,798,239 | 20.39 | |
| 513,643 | 2,232,680 | 23.01 | |
| 673,010 | 2,766,907 | 24.32 | |
| 562,179 | 2,624,689 | 21.42 | |
| 387,400 | 2,782,285 | 13.92 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRGX – CARGO Therapeutics, Inc. | CRNX – Crinetics Pharmaceuticals, Inc. |
| CTMX – CytomX Therapeutics, Inc. | DAWN – Day One Biopharmaceuticals, Inc. |
| DNLI – Denali Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io